Venture
Carmot Therapeutics Inc.
Latest Form D 2023-06-06- CIK 1490109
- State CA
- Biotechnology
- 6 Form D offerings since 2010-04-23
- Total sold
- $350M
- across 6 offerings
- Rounds
- 6
- Form D offerings since 2010-04-23
- Latest round
- $150M
- 2023-06-06 · 021-483450
- Investors
- 25
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2023-06-06 · $150M
- 2010-04-23$1.5M021-141033
- 2012-07-17$500K021-181381
- 2017-08-25$10.8M021-293514
- 2020-10-01$26.3M021-376820
- 2022-08-08$161M021-455238
- 2023-06-06$150M021-483450
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($161M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-483450 | First filed2023-06-06 | Latest2023-06-06 | Sought$150M | Sold$150M | Investors25 | Exemptions506(b) |
| 021-455238 | First filed2022-08-08 | Latest2022-08-08 | Sought$161M | Sold$161M | Investors15 | Exemptions506(b) |
| 021-376820 | First filed2020-10-01 | Latest2020-10-01 | Sought$46.9M | Sold$26.3M | Investors6 | Exemptions506(b) |
| 021-293514 | First filed2017-08-25 | Latest2017-08-25 | Sought$15.4M | Sold$10.8M | Investors4 | Exemptions506(b) |
| 021-181381 | First filed2012-07-17 | Latest2012-07-17 | Sought$1.2M | Sold$500K | Investors2 | Exemptions506 |
| 021-141033 | First filed2010-04-23 | Latest2010-04-23 | Sought$1.5M | Sold$1.5M | Investors2 | Exemptions506 |
Who backs Carmot Therapeutics Inc. — 2 inferred investors — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2023-06-06
| Name | Relationship |
|---|---|
| Stig K. Hansen, Ph.D. | RelationshipDirector |
| Tim Kutzkey | RelationshipDirector |
| Peter Svennilson | RelationshipDirector |
| Aetna Wun Trombley | RelationshipDirector |
| Timothy Garnett | RelationshipDirector |
| Heather Turner | RelationshipExecutive Officer, Director |
| Anne Phillips, M.D. | RelationshipDirector |
Facts
As its latest Form D states them
- Industry
- Biotechnology
- State
- California (CA)
- Exemptions
- Rule 506(b); Rule 506
- First filed
- 2010-04-23
- Latest filing
- 2023-06-06
Who backs Carmot Therapeutics Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗